期刊文献+

氟代马蹄金素二肽模拟物的合成及其抗HBV活性初探 被引量:1

Synthesis and anti-HBV activity of fluorinated dipeptidomimetics of Matijin-Su
原文传递
导出
摘要 为拓展马蹄金素(MTS)二肽衍生物结构多样性,以获得新型抗乙肝病毒活性目标分子,本文采用生物电子等排体替换法,将MTS二肽衍生物中容易水解的酰胺键以含有三氟甲基取代的甲氨基单元替换,设计合成了新型氟代MTS二肽模拟物。所有目标化合物均通过^(1)H NMR、^(13)C NMR、^(19)F NMR、HRMS或ESI-MS进行了结构确证,通过单晶X射线衍射测定了化合物10′的晶体结构,并以HepG22.2.15细胞模型对其进行了体外抗乙肝病毒(HBV)测试,结果显示所有目标化合物对HBV DNA的复制均有抑制作用,14e、14f、14k的IC_(50)值分别为0.37、0.29、0.79μmol·L^(-1)。 To expand the structural diversity of Matijin-Su(MTS)derivatives and explore novel anti-HBV activity compounds,a series of fluorinated dipeptidomimetics of MTS were designed and synthesized by using trifluoromethyl substituted methylamine unit as bioisostere to replace the amide bond of the MTS derivatives.The structures of all target compounds were confirmed by ^(1)H NMR,^(13)C NMR,^(19)F NMR,HRMS,or ESI-MS,and the crystal structure of 10'was determined by X-ray single crystal diffraction.Their inhibitory activity against hepatitis B virus(HBV)in vitro were evaluated using HepG22.2.15 cell model.The results showed that all target compounds had inhibitory effect on HBV DNA replication,the IC_(50) of 14e,14f,and 14k were 0.37,0.29,and 0.79μmol·L^(-1),respectively.
作者 黄维杰 况安香 邵晓霜 曾晓萍 梁光义 孟雪玲 徐必学 HUANG Wei-jie;KUANG An-xiang;SHAO Xiao-shuang;ZENG Xiao-ping;LIANG Guang-yi;MENG Xue-ling;XU Bi-xue(State Key Laboratory of Functions and Applications of Medicinal Plants,Guizhou Medical University,Guiyang 550014,China;The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences/Guizhou Provincial Engineering Research Center for Natural Drugs,Guiyang 550014,China;Guizhou University of Traditional Chinese Medicine,Guiyang 550025,China;School of Pharmacy,Guizhou Medical University,Guiyang 550025,China)
出处 《药学学报》 CAS CSCD 北大核心 2022年第4期1095-1105,共11页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81760623) 贵州省高层次创新人才培养计划项目(黔科合平台人才[2016] 5678)。
关键词 马蹄金素二肽模拟物 三氟甲基 合成 抗HBV活性 dipeptidomimetics of Matijin-Su trifluoromethyl synthesis anti-HBV activity
  • 相关文献

参考文献7

二级参考文献69

  • 1孙志国.拉米夫定停药反跳致重型肝炎2例分析[J].医学信息(西安上半月),2005,18(12):1749-1749. 被引量:1
  • 2周卫平.单乙醇胺在药物合成中的应用[J].医药化工,2006(7):21-24. 被引量:1
  • 3邓艳君,石静波,姜力勋,高静,姚其正.嘧啶并呋咱核苷衍生物的制备及其活性初探[J].化学学报,2006,64(18):1911-1915. 被引量:10
  • 4王哲清.实用高效的酰胺键形成试剂[J].中国医药工业杂志,2006,37(12):855-858. 被引量:3
  • 5包俊 冉懋雄 陆科闵 等.贵州苗族医药研究与开发[M].贵阳:贵州科技出版社,1999.200.
  • 6贵州省卫生厅.“贵州省药品标准”1994年版,贵阳,1994.25
  • 7Junichi Kitajima, Nobuyuki Suzuki,Toru ishikawa, et al. New hemiterpenoid pentol and monoterpenoid glycoside of Torillis japonica fruit, and consideration of the origin of apiose. Chemical and Pharmaceutical Bullin, 1998,46(10):1583~1586
  • 8Hirozi Suzuki, Tsutomu Ikeda, Takashi Matsumoto, et al.Polyphenol components in culured cells of amaeha(Hydrangea macrophylla Seringe var. Thunbergii Makino). Agric Biol Chem, 1978,42(6):1133~1137
  • 9Pang R, Tao JY, Zhang SL, et al. In vitro antiviral activity of lute- in against hepatitis B virus[J]. Phytother Res,2010,24 ( 11 ) : 1627 - 1630.
  • 10刘青川,葛敏,黄正明,等.苯丙氨酸二肽类化合物Y101对2.2.15细胞内HBVDNA和cceDNA的抑制作用[M].中国成人医药教育论坛[2010(3)].2010.

共引文献53

同被引文献29

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部